Last-minute Expo+ 2-for-1 passes available for TechCrunch Disrupt 2024

Date:

Share post:


Time is ticking! Just two weeks until the doors to TechCrunch Disrupt 2024 open. To ensure no one misses this highly anticipated event, we’re offering Expo+ 2-for-1 passes for the final days leading up to Disrupt 2024.

Bring a friend, colleague, or family member to Moscone West in San Francisco from October 28-30. Get two Expo+ passes for half the price of one. This limited offer is available until October 27 at 11:59 p.m. PT. All ticket prices will increase on the first day of Disrupt 2024.

Get your discounted two Expo+ Passes here.

What’s included with Expo+ Pass

  • Full access to the bustling Expo Hall: Connect with 10,000 attendees, explore startups’ innovations, and watch pitches on the Pitch Showcase Stage.
  • Attend Breakout Sessions: Participate in first-come, first-served Q&A sessions hosted by industry experts.
  • Join Braindate meetings: Connect through in-person discussions, whether 1:1 or in small groups, with fellow attendees and industry leaders on topics posted in the Braindate app.
  • Women of Disrupt Breakfast reception: Enhance your leadership skills and overcome imposter syndrome with advice from female founders. Join us on October 29, from 8 to 10 a.m. at Deal Flow Cafe (located on the third floor). Limited space — first come, first served. This is a women-exclusive event.
  • Side Events: Be the first to explore and register for company-hosted Side Events during Disrupt Week. Keep the excitement going beyond the main event.

Don’t miss Disrupt 2024

Disrupt 2024 is just around the corner! Don’t miss out on your final chance to pocket real savings before the offer ends on October 27 at 11:59 p.m. PT. Register for your Expo+ 2-for-1 passes here.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

OpenAI’s GPT-5 reportedly falling short of expectations

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t...

OpenAI announces new o3 model — but you can’t use it yet

Welcome back to Week in Review. This week, we’re looking at OpenAI’s last — and biggest —...

Google pushes back against DOJ’s ‘interventionist’ remedies in antitrust case

Google has offered up its own proposal in a recent antitrust case that saw the US Department...

If climate tech is dead, what comes next?

Humans have an innate desire to name things, but to be honest, we’re not always that good...

Hollywood angels: Here are the celebrities who are also star VCs

Becoming a venture capitalist has become the latest status symbol in Hollywood.  Everyone these days, from Olivia Wilde...

Meet Skyseed, a VC fund and incubator backing the Bluesky and AT Protocol ecosystem

On November 15, Peter Wang posted a message requesting ideas for a new incubator and fund to...

Sam Altman disputes Marc Andreessen’s description of AI meetings with Biden administration

Famed investor Marc Andreessen recently talked about meetings with Biden administration staff who gave him the impression...

EV startup Canoo places remaining employees on a ‘mandatory unpaid break’

Struggling electric van startup Canoo has placed its remaining employees on what it’s calling a “mandatory unpaid...